Evaluation of In vitro activity of tigecycline against multidrug-resistant clinical isolates
Introduction: Multiple drug resistance (MDR) of the bacteria is an issue across any health-care setting worldwide. This leads to prolonged hospital stay and high cost of treatment. One must be cautious to use reserve drugs such as imipenem, meropenem, colistin, polymyxin, and tigecycline. Tigecyclin...
Saved in:
Main Authors: | Livya A Wilson (Author), Thomas S Kuruvilla (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
<it>In vitro </it>activity of tigecycline in combination with various antimicrobials against multidrug resistant <it>Acinetobacter baumannii</it>
by: Petrosillo Nicola, et al.
Published: (2009) -
In-vitro activity of tigecycline against multidrug-resistant Gram negative bacteria: The experience of a university hospital
by: Z. Elnasser, et al.
Published: (2021) -
<it>In vitro </it>activity of tigecycline and comparators against carbapenem-susceptible and resistant <it>Acinetobacter baumannii </it>clinical isolates in Italy
by: Carattoli Alessandra, et al.
Published: (2008) -
Evaluation of tigecycline activity in clinical isolates among Indian medical centers
by: Manoharan Anand, et al.
Published: (2010) -
In vitro activity of tigecycline against patient isolates collected during phase 3 clinical trials for hospital acquired pneumonia
by: Peter J. Petersen, et al.
Published: (2010)